Stock Scorecard



Stock Summary for Koninklijke Philips N.V. (PHG) - $27.15 as of 10/15/2025 7:54:20 AM EST

Total Score

6 out of 30

Safety Score

43 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for PHG

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for PHG

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for PHG

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for PHG

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for PHG (43 out of 100)

Stock Price Rating (Max of 10) 7
Historical Stock Price Rating (Max of 10) 8
Stock Price Trend (Max of 10) 2
Book Value (Max of 10) 5
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 2
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 6
Operating Margin (Max of 10) 2
Trading Volume (Max of 10) 6
Price to Earnings (Max of 10) 1
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for PHG

Why Royal Philips ( PHG ) is a Top Value Stock for the Long-Term 10/8/2025 1:40:00 PM
Here's Why Royal Philips ( PHG ) is a Strong Momentum Stock 10/6/2025 1:50:00 PM
Official Philips Home Access Online Store Has Been Launched - Up to 60 % OFF, Free Shipping and Exclusive Giveaways 9/29/2025 11:56:00 AM
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick 9/10/2025 1:40:00 PM
Here's Why Royal Philips ( PHG ) is a Strong Value Stock 8/25/2025 1:40:00 PM
AI in Remote Patient Monitoring ( RPM ) Market to Reach USD 8,438.5 Million by 2030 | MarketsandMarkets™ 8/20/2025 12:00:00 PM
Why Royal Philips ( PHG ) is a Top Momentum Stock for the Long-Term 8/15/2025 1:50:00 PM
Philips Home Access to showcase smart lock and video doorbell innovations at Ace Hardware Fall Convention 2025 8/12/2025 3:02:00 PM
Why Royal Philips ( PHG ) is a Top Value Stock for the Long-Term 8/8/2025 1:40:00 PM
Philips Q2 Earnings and Revenues Decline Year Over Year, Shares Fall 7/30/2025 4:53:00 PM

Financial Details for PHG

Company Overview

Ticker PHG
Company Name Koninklijke Philips N.V.
Country USA
Description Koninklijke Philips NV, commonly known as Philips, is a leading global healthcare technology company headquartered in Amsterdam, the Netherlands. Focused on improving people's health and enabling better outcomes across the healthcare continuum, Philips develops innovative solutions in areas such as diagnostic imaging, patient monitoring, and personal health. With a strong presence in North America and Greater China, the company leverages advanced technology and digital health platforms to enhance the quality of care and drive operational efficiencies. Philips is committed to sustainability and has integrated environmental considerations into its business strategies, positioning itself as a key player in the evolving health technology landscape.
Sector Name HEALTHCARE
Industry Name MEDICAL DEVICES
Most Recent Quarter 6/30/2025
Next Earnings Date 11/4/2025

Stock Price History

Last Day Price 27.15
Price 4 Years Ago 34.14
Last Day Price Updated 10/15/2025 7:54:20 AM EST
Last Day Volume 586,212
Average Daily Volume 607,979
52-Week High 31.15
52-Week Low 20.65
Last Price to 52 Week Low 31.48%

Valuation Measures

Trailing PE 144.74
Industry PE 41.98
Sector PE 40.41
5-Year Average PE 23.45
Free Cash Flow Ratio 14.14
Industry Free Cash Flow Ratio 36.06
Sector Free Cash Flow Ratio 29.23
Current Ratio Most Recent Quarter 1.26
Total Cash Per Share 1.92
Book Value Per Share Most Recent Quarter 10.92
Price to Book Ratio 2.17
Industry Price to Book Ratio 3.89
Sector Price to Book Ratio 32.01
Price to Sales Ratio Twelve Trailing Months 1.46
Industry Price to Sales Ratio Twelve Trailing Months 5.86
Sector Price to Sales Ratio Twelve Trailing Months 15.78
Analyst Buy Ratings 1
Analyst Strong Buy Ratings 2

Share Statistics

Total Shares Outstanding 950,574,000
Market Capitalization 25,808,084,100
Institutional Ownership 5.34%

Dividends

Ex-Dividend Date 5/13/2025
Previous Dividend Amount 0.8443
Current Dividend Amount 0.9673
Total Years Dividend Increasing 0
Trailing Annual Dividend Rate 0.97
Trailing Annual Dividend Yield 3.52%
Forward Annual Dividend Rate 0.97
Forward Annual Dividend Yield 3.52%
5-Year Dividend Payments Count 3
3-Year Average Dividend Yield 5.84%
5-Year Average Dividend Yield 4.32%
1-Year Dividend Growth Rate Percentage 14.57%
3-Year Dividend Growth Rate Percentage 0.53%
5-Year Dividend Growth Rate Percentage 1.83%
All-Time Dividend Growth Rate Percentage 10.10%
Dividend Payout Ratio 509.11%

Income Statement

Quarterly Earnings Growth YOY -46.90%
Annual Earnings Growth -50.64%
Reported EPS 12 Trailing Months 0.19
Reported EPS Past Year 0.57
Reported EPS Prior Year 1.39
Net Income Twelve Trailing Months 162,000,000
Net Income Past Year -702,000,000
Net Income Prior Year -466,000,000
Quarterly Revenue Growth YOY -2.80%
5-Year Revenue Growth -1.55%
Operating Margin Twelve Trailing Months 9.24%

Balance Sheet

Total Cash Most Recent Quarter 1,822,000,000
Total Cash Past Year 2,401,000,000
Total Cash Prior Year 1,869,000,000
Net Cash Position Most Recent Quarter -5,360,000,000
Net Cash Position Past Year -3,793,000,000
Long Term Debt Past Year 6,194,000,000
Long Term Debt Prior Year 6,095,000,000
Total Debt Most Recent Quarter 7,182,000,000
Equity to Debt Ratio Past Year 0.66
Equity to Debt Ratio Most Recent Quarter 0.59
Total Stockholder Equity Past Year 12,006,000,000
Total Stockholder Equity Prior Year 12,028,000,000
Total Stockholder Equity Most Recent Quarter 10,379,000,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 269,000,000
Free Cash Flow Per Share Twelve Trailing Months 0.28
Free Cash Flow Past Year 880,000,000
Free Cash Flow Prior Year 1,615,000,000

Options

Put/Call Ratio 1.59
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.15
MACD Signal 0.11
20-Day Bollinger Lower Band 21.80
20-Day Bollinger Middle Band 25.92
20-Day Bollinger Upper Band 30.04
Beta 0.84
RSI 58.96
50-Day SMA 25.19
150-Day SMA 22.49
200-Day SMA 22.67

System

Modified 10/14/2025 6:51:30 AM EST